Private Institute Briefs

First Publication For Seattle Theorist A 72-year-old retired aerospace engineer with a new theory of life will finally get a hearing in a peer-reviewed journal. Dwight H. Bulkley, director of the Seattle Institute for the Life Sciences, is publishing his paper, “Electromagnetic Theory of Life,” in next month’s issue of Medical-Hypotheses. Bulkley, who describes the Seattle Institute as a “think-tank” of about two dozen people who meet at their homes for informal d

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

A 72-year-old retired aerospace engineer with a new theory of life will finally get a hearing in a peer-reviewed journal. Dwight H. Bulkley, director of the Seattle Institute for the Life Sciences, is publishing his paper, “Electromagnetic Theory of Life,” in next month’s issue of Medical-Hypotheses. Bulkley, who describes the Seattle Institute as a “think-tank” of about two dozen people who meet at their homes for informal discussions about biology, believes that the conventional model of life as a chemical phenomenon contains at least 250 contradictions, which he hopes to resolve with a new paradigm: “life-as-physics.” His past efforts to offer his views to the scientific community include presentations at meetings of the American Association for the Advancement of Science and an-open letter to broadcaster Bill Moyers in which he declared “that life is not a function of a series of chemical reactions (with mere electron transfers between donor and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies